The IGLoS signature consists of six immune infiltration‐related genes associated with the survival of diffuse patients with glioma, which are CCL19, ICOSLG, IL11, PTGES, TNFAIP3, and TRAF3IP3. This evidence concerns the gene TNFAIP3 and glioma.